The global Cell and Gene Therapy Market is valued at $20.5 billion in 2024 and is projected to reach a value of $128.8 ...

Like other developers of recently approved gene therapies, Bluebird has been slow to generate demand for its products. That reflects challenges in securing reimbursement from payers stemming from ...

The Global Recombinant DNA Technology Market was valued at approximately USD $$ billion in 2022 and is expected to grow at a healthy CAGR of over $% from 2023 to 2030. Recombinant DNA Technology ...

The global Heart Failure Drugs Market is valued at $8.6 billion in 2024 and is projected to reach a value of $21.4 billion by ...

2024年12月，辉瑞终止了与Sangamo Therapeutics在A型血友病基因疗法giroctocogene fitelparvovec的合作，将该基因治疗的权益退还给了Sangamo。 近日，基因治疗先驱公司蓝鸟更是在连续几年的挣扎后， ...

Objectives Tendinopathy is a frequent clinical problem and represents an extraordinary health economic and socioeconomic burden with high unmet medical needs. Recent clinical evidence suggests ...